 and was associated with a lower, statistically
not signiÔ¨Åcant, incidence of VTE (RR, 0.37; 95% CI, 0.081.78).260 However, most studies evaluating surgery and
topical treatments did not report SVT progression, VTE,
or adverse events.34
A recent analysis from the RIETE registry of patients
with thrombosis involving main trunk of the GSV within
